News|Articles|June 23, 2026

Pipeline Review: Alzheimer Disease Therapies by Mechanism of Action

Fact checked by: Marco Meglio

The 2026 Alzheimer disease drug development landscape highlights a growing shift toward diverse disease-modifying strategies, from amyloid and tau targeting to metabolic and neuroprotective approaches.

June is Alzheimer’s & Brain Awareness Month, an annual observance dedicated to raising awareness of Alzheimer disease (AD), related dementias, and the importance of maintaining brain health across the lifespan. Established by the Alzheimer’s Association in 2014, the campaign highlights the growing burden of AD while promoting education on risk reduction, early detection, diagnosis, and advances in research and treatment.